Trending...
- Attn: Newspapers: EXTRA! EXTRA! Read all about it! Get in on Giant New Advertising Revenues NOW!
- PR Support That Cuts the Mustard for Busy Founders
- California: Governor Newsom announces appointments 12.30.2025
SAN DIEGO--(BUSINESS WIRE)--Kurin, Inc., the inventor and manufacturer of the Kurin® blood culture collection sets announced record revenues for 2022. Revenue growth in 2022 was dramatic, increasing over 60% over 2021 revenue.
"We are pleased with Kurin's success, as demonstrated by the impressive growth over 2021, which also saw a large revenue increase over the prior year," said Bob Rogers, CEO of Kurin, Inc. "Our fourth quarter revenue reflected our highest sales quarter by some distance and we are very well positioned for continued strong growth in 2023."
"In addition, we continue to roll out our proprietary Advance™ push-button needle, providing vertical integration that increases our shareholder value," said Mr. Rogers. "We continue to build upon the company's strong financial position and have accelerated our hiring to accommodate this growth."
Kurin's revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening C. diff. infection.
More on The Californer
About Kurin, Inc.
Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com.
Contacts
Matt Heindel
Kurin, Inc.
858-752-9514
mattheindel@kurin.com
"We are pleased with Kurin's success, as demonstrated by the impressive growth over 2021, which also saw a large revenue increase over the prior year," said Bob Rogers, CEO of Kurin, Inc. "Our fourth quarter revenue reflected our highest sales quarter by some distance and we are very well positioned for continued strong growth in 2023."
"In addition, we continue to roll out our proprietary Advance™ push-button needle, providing vertical integration that increases our shareholder value," said Mr. Rogers. "We continue to build upon the company's strong financial position and have accelerated our hiring to accommodate this growth."
Kurin's revolutionary approach to the contaminated blood culture problem is an elegantly simple, intuitive design that requires no additional user steps. Kurin passively sidelines potential contaminants during blood culture collection. Kurin is a simply better and more sustainable approach over conventional mechanical diversion. Contaminated blood cultures are a significant problem, as roughly one-third of the positive results are wrong, exposing these patients to unnecessary antibiotics, extending hospital stays and impacting larger community health issues, such as antimicrobial resistance and the life-threatening C. diff. infection.
More on The Californer
- Victoria Carson's Album "Glow" Dropped New Year's Day!
- Inkdnylon Launches Bilingual Ask Inkdnylon Platform
- Annotatable AI Redefines Web Interaction with the World's Most Powerful AI-Driven Web Annotations
- ezPaycheck 2026 Simplifies Qualified Tip Payroll for Restaurants
- DeliverySoCal.com Launches Free Delivery Driver Pay Calculator to Help Gig Workers Track Earnings
About Kurin, Inc.
Kurin, Inc., a certified Minority Business Enterprise (MBE), is focused on the design, development, manufacture, marketing, and sale of products that help healthcare providers reduce contaminated blood cultures. Kurin, manufactured in San Diego, CA, has received FDA 510(k) market clearance. For more information about Kurin, visit the website at www.kurin.com.
Contacts
Matt Heindel
Kurin, Inc.
858-752-9514
mattheindel@kurin.com
Filed Under: Business
0 Comments
Latest on The Californer
- California: Governor Newsom announces appointments 1.2.2026
- 11 Wins, Limitless Impact: 2025 Viddy Awards Honor Scientology Media Productions
- Car Wash in Northridge Near CSUN
- Marc Yaffee Comes To Stubby's Cool January 17
- Website Traffic Generator – GA4 Tracking
- Introducing "Like A Virgin" — A New Bridal Brand for the Modern, Untraditional Bride
- FrostSkin Launches Kickstarter Campaign for Patent-Pending Instant-Chill Water Purification Bottle
- The New Monaco of the South (of Italy)
- Mike Diamond Launches Free Sewer Camera Inspection Offer in Los Angeles
- ExecLayer Launches Patent-Pending Generative Ops Platform for Enterprise Operations
- Nine Years On, Still Incredible: Lightning Motorcycles Defies EV Obsolescence
- Reinforcement Learning Accelerates Model-free Training of Optical AI Systems
- Melospeech Reports 96% of Therapy Goals Met, Exceeded, or Showing Meaningful Progress at Six-Month Reassessment in 2025
- Lick Personal Oils Introduces the Ultimate Valentine's Day Gift Collection for Romantic, Thoughtful Gifting
- California: Governor Newsom honors fallen CAL FIRE Engineer
- California: Federal court finally ends illegal federalization of National Guard after Trump gives up, Governor Newsom directs leadership to quickly send soldiers home to families
- NUEVO EN 2026: Leyes de California que entran en vigencia en el nuevo año
- NEW IN 2026: California laws taking effect in the new year
- Glossa Launches Slack Integration to Capture Requirements Where Teams Work
- PowerTribe Releases New Heavy Metal Single "The Earthlings Have Died"